The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of around 5.6% during the forecast period (2021-2027). The key factor to drive the market growth includesthe increasing prevalence of diabetes that results in increased chances of nephrotic syndrome. For instance, In the European Union, approximately 32.3 million adults were diagnosed with diabetes in 2019, up from an estimated 16.8 million adults in 2000. In 2019, it was estimated that around 24.2 million people in Europe will be having diabetes but will go undiagnosed.Since 2000, the number of men diagnosed with diabetes has more than doubled, rising from about 7.3 million in 2000 to 16.7 million in 2019. Women with diabetes have also increased significantly, from 9.5 million in 2000 to 15.6 million in 2019.
To Request a Sample of our Report on Nephrotic Syndrome Diagnostics & Therapeutics Market: https://www.omrglobal.com/request-sample/nephrotic-syndrome-diagnostics-therapeutics-market
Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in April 2019, Angion announced a partnership agreement with Nephrotic Syndrome Study Network (NEPTUNE)in order to investigate ANG-3070. This clinical research is based on understanding and treatment of kidney disorders.These findings of the research will supportdetermining the inclusion requirements for a biomarker stratified prospective clinical trial evaluating the safety and efficacy of ANG-3070 in primary Focal segmental glomerulosclerosis (FSGS) patients, ensuring that the most likely patients benefit from treatment.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Diagnosis Test
- By Treatment
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-
(Get 15% Discount on Buying this Report)
A full Report of Nephrotic Syndrome Diagnostics & Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/nephrotic-syndrome-diagnostics-therapeutics-market
Global Nephrotic Syndrome Diagnostics & Therapeutics Market Report Segment
By Diagnosis Tests
- Urinalysis
- Blood Tests
- Kidney Biopsy
- Others (CT Scan, Renal Ultra-Sonography)
By Treatment
- Blood Pressure Lowering Medications
- Angiotensin-Converting Enzyme (ACE) Inhibitors
- Angiotensin Receptor Blockers (ARBs)
- Others (Renin Inhibitors and Benazepril)
- Immune System-Suppressing Medications
- Cholesterol-Reducing Medications
- Others (Blood Thinners)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
